Anne-Laure Seigne

  • Citations Per Year
Learn More
BACKGROUND Infliximab (IFX) infusions require repeated hospitalizations. The median duration of each hospitalization stay, including time for infusion and the cost for the health care system, are unknown. We assessed the extra burden of IFX infusions in inflammatory bowel disease (IBD). METHODS This was a prospective cross-sectional study enrolling all(More)
  • 1